Cargando…

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study

BACKGROUND: The effectiveness of anti-parasite treatment with benznidazole in the chronic Chagas disease (ChD) remains uncertain. We evaluated, using data from the NIH-sponsored SaMi-Trop prospective cohort study, if previous treatment with benznidazole is associated with lower mortality, less advan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardoso, Clareci Silva, Ribeiro, Antonio Luiz P., Oliveira, Claudia Di Lorenzo, Oliveira, Lea Campos, Ferreira, Ariela Mota, Bierrenbach, Ana Luiza, Silva, José Luiz Padilha, Colosimo, Enrico Antonio, Ferreira, João Eduardo, Lee, Tzong-Hae, Busch, Michael P., Reingold, Arthur Lawrence, Sabino, Ester Cerdeira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211620/ https://www.ncbi.nlm.nih.gov/pubmed/30383777 http://dx.doi.org/10.1371/journal.pntd.0006814

Ejemplares similares

Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project
por: Quintino, Nayara Dornela, et al.
Publicado: (2020)

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile
por: Cardoso, Clareci Silva, et al.
Publicado: (2016)

Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort
por: Oliveira, Claudia Di Lorenzo, et al.
Publicado: (2021)

Serological screening for Chagas disease in an endemic region of Northern Minas Gerais, Brazil: the SaMi-Trop project
por: Cruz, Dardiane Santos, et al.
Publicado: (2021)

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
por: Di Lorenzo Oliveira, Claudia, et al.
Publicado: (2020)

Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study
por: Martins Barros, Isabella Morais, et al.
Publicado: (2021)

Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients–The SaMi-Trop cohort
por: Brito, Bruno Oliveira de Figueiredo, et al.
Publicado: (2021)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016)

Chagas disease and perceived quality of life: a cross-sectional study
por: Baldoni, Nayara Ragi, et al.
Publicado: (2023)

Lack of evidence of seronegative infection in an endemic area of Chagas disease
por: de Oliveira, Léa Campos, et al.
Publicado: (2019)

Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)

Correction: Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients–the SaMi-Trop cohort
Publicado: (2022)

Correction to: Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
Publicado: (2021)

Hospitalizations due to gastrointestinal Chagas disease: National registry
por: Bierrenbach, Ana Luiza, et al.
Publicado: (2022)

Failure to use health services by people with Chagas disease: Multilevel analysis of endemic area in Brazil
por: Damasceno, Renata Fiúza, et al.
Publicado: (2022)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018)

Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort
por: Ferreira, Ariela Mota, et al.
Publicado: (2020)

Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Quality of life in patients with Chagas disease and the instrument used: an integrative review
por: Baldoni, Nayara Ragi, et al.
Publicado: (2021)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2023)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
por: Gontijo, Maria Katarine Costa Lucas, et al.
Publicado: (2020)

Screening for Chagas disease from the electrocardiogram using a deep neural network
por: Jidling, Carl, et al.
Publicado: (2023)

Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
por: Sesti-Costa, Renata, et al.
Publicado: (2014)

Overview of Chagas disease surveillance in an endemic region in Southeastern Brazil
por: Rafael, Aline Ferreira, et al.
Publicado: (2023)

Mortality among blood donors seropositive and seronegative for Chagas disease (1996–2000) in São Paulo, Brazil: A death certificate linkage study
por: Capuani, Ligia, et al.
Publicado: (2017)

Correction: Mortality among blood donors seropositive and seronegative for Chagas disease (1996–2000) in São Paulo, Brazil: A death certificate linkage study
por: Capuani, Ligia, et al.
Publicado: (2020)

Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease
por: Fragata-Filho, Abilio Augusto, et al.
Publicado: (2016)

Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease
por: Pinto, Ana Yecê das Neves, et al.
Publicado: (2013)

Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017)

Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
por: Zrein, Maan, et al.
Publicado: (2018)

Two-year death prediction models among patients with Chagas Disease using machine learning-based methods
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
por: Mazzeti, Ana Lia, et al.
Publicado: (2023)

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole
por: Robello, Carlos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_al90jbr42ku46183uad74n9bds